INmune Bio Inc.
June 27, 2025 - by Joey Ramson
Shares of $INMB have had quite the ride today after starting the day up due to positive expectations from the initial data from its Phase 2 MINDFuL trial for XPro in early Alzheimer’s disease. But then news came of the announcement of a $19 million equity offering. The company plans to issue 3 million shares at $6.30 each.
